FMR1 and fragile X-associated tremor/ataxia syndrome: We identified changes in FMR1 expression, cellular proportion, global gene expression, and oligodendrocyte cortical development that challenge current assumptions about molecular mechanisms underlying FXTAS pathogenesis and specifically implicate glial dysregulation as critical in fragile X molecular neuropathology.